Intrinsic Value of S&P & Nasdaq Contact Us

Kymera Therapeutics, Inc. KYMR

NASDAQ Global Market

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$117.31
+30.5%

Kymera Therapeutics, Inc. (KYMR) current share price is $89.87. The gold spot price is $4,808.10 per troy ounce. Using the formula: KYMR in gold = $89.87 × 31.1035 ÷ $4,808.10 = 0.5813 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of KYMR when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding KYMR shares over the measured period.

KYMR in US Dollars
Gold in US Dollars
KYMR in Gold (grams per share)

Real Wealth Growth Rate

KYMR
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{KYMR}_{\text{gold}}(t) = \frac{P_{\text{KYMR}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{KYMR}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{KYMR}_{\text{gold}}^{(T)}}{\text{KYMR}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{KYMR}_\text{gold}^{(0)}$ = initial gold-price, $\text{KYMR}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
AGIO
AGIO
Agios Pharmaceuticals, Inc.
$33.30
+0.45%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
NRIX
NRIX
Nurix Therapeutics, Inc.
$16.30
+2.45%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message